Cargando…

Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy

Ovarian Hyperstimulation Syndrome (OHSS) is an uncommon but serious complication occurring in patients undergoing ovarian stimulation. It is characterized by ovarian enlargement, nausea, vomiting, abdominal pain/distension, and reduction in urine output. However, OHSS may rarely evolve into a life-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Guardo, Federica, Lello, Chiara, Incognito, Giosuè Giordano, Bruno, Maria Teresa, Palumbo, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862679/ https://www.ncbi.nlm.nih.gov/pubmed/36675543 http://dx.doi.org/10.3390/jcm12020614

Ejemplares similares

Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2015)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

Erratum to: Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2016)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
por: Fiedler, Klaus, et al.
Publicado: (2012)

Interleukin-6 as A Useful Predictor of Endometriosis-Associated Infertility: A Systematic Review
por: Giordano Incognito, Giosuè, et al.
Publicado: (2023)

Outpatient Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) with Placement of Pigtail Catheter
por: Abuzeid, M., et al.
Publicado: (2014)

Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)
por: Farkas, Balint, et al.
Publicado: (2020)

Melatonin Ameliorates Ovarian Hyperstimulation Syndrome (OHSS) through SESN2 Regulated Antiapoptosis
por: Zheng, Min, et al.
Publicado: (2023)

Nintedanib Treatment After Ovulation is an Effective Therapeutic Strategy for the Alleviation of Ovarian Hyperstimulation Syndrome (OHSS) in a Mouse Model
por: Jiang, Shutian, et al.
Publicado: (2022)

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021)

The Use of High Dose Letrozole in Ovulation Induction and Controlled Ovarian Hyperstimulation
por: Pritts, Elizabeth A., et al.
Publicado: (2011)

Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)—a retrospective case–control study
por: Nouri, Kazem, et al.
Publicado: (2014)

Ovarian Hyperstimulation Syndrome (OHSS) requiring Intensive Care Unit (ICU) admission between 1996-2020 in England, Wales, and Northern Ireland
por: Abbara, Ali, et al.
Publicado: (2022)

New algorithm for OHSS prevention
por: Papanikolaou, Evangelos G, et al.
Publicado: (2011)

Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers
por: Goldrat, Oranite, et al.
Publicado: (2019)

Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy
por: Abbara, Ali, et al.
Publicado: (2015)

A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS
por: Yanagihara, Yasuho, et al.
Publicado: (2021)

Comparison of Letrozole and Clomiphene Citrate Efficacy along with Gonadotrophins in Controlled Ovarian Hyperstimulation for Intrauterine Insemination Cycles
por: HaqNawaz, Fauzia, et al.
Publicado: (2013)

Zinc finger gene 217 (ZNF217) Promoted Ovarian Hyperstimulation Syndrome (OHSS) through Regulating E(2) Synthesis and Inhibiting Thrombospondin-1 (TSP-1)
por: Zhai, Junyu, et al.
Publicado: (2017)

OHSS Free Clinic
por: Devroey, P., et al.
Publicado: (2011)

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011)

Prevention of Ovarian Hyperstimulation Syndrome: A Review
por: Smith, Vinayak, et al.
Publicado: (2015)

A Prospective Randomised Comparative Clinical Trial Study of Luteal Phase Letrozole versus Ganirelix Acetate Administration to Prevent Severity of Early Onset OHSS in ARTs
por: Choudhary, Rana Afzal, et al.
Publicado: (2021)

Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011)

Ovarian and intellectual hyperstimulation
por: Quaas, Alexander M.
Publicado: (2021)

Severe Ovarian Hyperstimulation Syndrome in a Woman With Breast Cancer Under Letrozole Triggered With GnRH Agonist: A Case Report and Review of the Literature
por: Iorio, Giuseppe Gabriele, et al.
Publicado: (2021)

Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic
por: Banker, Manish, et al.
Publicado: (2015)

GnRH Analogues in the Prevention of Ovarian Hyperstimulation Syndrome
por: Alama, Pilar, et al.
Publicado: (2013)

Cesarean Scar Pregnancy and Successful Ultrasound-Guided Removal after Uterine Artery Ligation
por: Leanza, Vito, et al.
Publicado: (2023)

Are Pregnancy Rates Compromised Following Embryo Freezing to Prevent OHSS?
por: Fitzmaurice, Gerard J, et al.
Publicado: (2008)

Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
por: Huang, Jianfang, et al.
Publicado: (2022)

Comparison of bromocriptine and hydroxyethyl starch in the prevention of ovarian hyperstimulation syndrome
por: Zhang, Qiaoli, et al.
Publicado: (2022)

Comparison of Maternal and Neonatal Outcomes between SARS-CoV-2 Variants: A Retrospective, Monocentric Study
por: Incognito, Giosuè Giordano, et al.
Publicado: (2023)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015)

Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?
por: Yumuşak, Ömer Hamid, et al.
Publicado: (2014)

Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)

A Retrospective Study of Letrozole Treatment Prior to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization at Risk of Ovarian Hyperstimulation Syndrome
por: Chen, Yilu, et al.
Publicado: (2018)

Renal and Hepatic Functions after A Week of Controlled Ovarian Hyperstimulation during In Vitro Fertilization Cycles
por: Romito, Ilaria, et al.
Publicado: (2017)

Ovarian Hyperstimulation Syndrome: Current Views on Pathophysiology, Risk Factors, Prevention, and Management
por: Alper, Michael M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_s8boq9juvihg0kiq3vd9mogl6k